Search
04/09/2021
IO Learning invited Allison S. Aguado, MD, to discuss her 2021 Society of Interventional Radiology (SIR) presentation on the efficacy of minimally invasive interventional radiology treatments in pediatric cancer patients.
03/30/2021
Pivotal study to evaluate the use of novel liquid embolic versus standard of care in treating malignant and benign hypervascular tumors.
03/30/2021
Fluidx Medical’s GPX™ embolic device demonstrates versatility and control in oncology clinical use.
03/25/2021
Data presented at SIR 2021 confirm safety and dose-efficacy relationship
03/18/2021
Treatment is the only radioembolization treatment approved for U.S. patients with hepatocellular carcinoma
03/16/2021
Patients with debilitating bone tumors experienced improved quality of life in as little as 3 days.
03/04/2021
NEWS PROVIDED BY GO2 Foundation for Lung Cancer
SAN CARLOS, Calif. and WASHINGTON, March 4, 2021 /PRNewswire/ -- GO2 Foundation for Lung Cancer (GO2 Foundation) announced its leadership in the…
03/01/2021
Blue Earth Diagnostics utilizing ERT imaging solution to evaluate a novel imaging agent for potential use to inform brain metastases disease management
02/23/2021
Earlier this year, the Busch Clinic added Profound Medical’s TULSA system to its treatment options. TULSA, also called “inside-out” ablation, uses a unique cooling system to provide thermal protection of important anatomy.
02/18/2021
Pavan Khanna, MD, discusses the evolution of Y-90 for the treatment of HCC and reviews the LEGACY and DOSISPHERE trials, which highlight how TheraSphere™ is progressing Y-90 therapy towards more advanced dosimetry techniques and personalization.
Back to Top